|
Control
|
DKA
|
NKH
|
---|
Before treatment
|
After treatment
|
Before treatment
|
After treatment
|
---|
SOD (kU/L)
|
89.56 ± 14.16
|
48.76 ± 18.33a
|
69.52 ± 16.31ab
|
53.52 ± 14.70a
|
70.35 ± 13.80ab
|
MDA (µmol/L)
|
5.23 ± 2.57
|
11.37 ± 3.66a
|
7.64 ± 2.90ab
|
8.57 ± 3.01a
|
6.07 ± 2.67ab
|
TAC (kU/L)
|
29.51 ± 11.49
|
20.39 ± 10.61a
|
24.27 ± 10.05ab
|
20.95 ± 12.41a
|
23.02 ± 11.23ab
|
8-Iso-PGF2α (µg/L)
|
6.70 ± 2.33
|
18.42 ± 5.78a
|
15.14 ± 6.21ab
|
20.90 ± 4.70a
|
13.44 ± 6.71ab
|
Adiponectin (µg/L)
|
9.89 ± 1.63
|
5.77 ± 1.55a
|
7.12 ± 1.63ab
|
5.23 ± 1.11a
|
8.06 ± 1.56ab
|
Leptin (µg/L)
|
8.91 ± 1.73
|
6.07 ± 2.45a
|
8.45 ± 2.13b
|
5.91 ± 1.07a
|
8.78 ± 2.65
|
Restistin (µg/L)
|
3.21 ± 1.07
|
8.35 ± 1.83a
|
6.24 ± 1.50ab
|
9.23 ± 2.06a
|
7.14 ± 1.99ab
|
- DKA: diabetic ketoacidosis group; NKH: non-ketotic hyperglycemia group; control group: healthy individuals
- aP < 0.05, compared with controls
- bP < 0.05, compared with the same group before treatment